The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis.

Saved in:
Bibliographic Details
Title: The autophilic anti-CD20 antibody DXL625 displays enhanced potency due to lipid raft-dependent induction of apoptosis.
Authors: Bingaman MG; InNexus Biotechnology Inc, Scottsdale, Arizona, USA., Basu GD, Golding TC, Chong SK, Lassen AJ, Kindt TJ, Lipinski CA
Source: Anti-cancer drugs [Anticancer Drugs] 2010 Jun; Vol. 21 (5), pp. 532-42.
Publication Type: Journal Article
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1473-5741
DOI:10.1097/CAD.0b013e328337d485